| Sanofi-Aventis (Suisse) SA - Clexane 40 mg/0.4 ml, solution injectable |
| 49456 | | 02 | | Clexane 40 mg/0.4 ml | | solution injectable | | B01AB05 | | Enoxaparin | | 31.08.1988 | | |
|
| Composition |
| enoxaparinum natricum 40 mg corresp. 4000 U.I. anti-Xa, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 40 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 40 mg |
| | | | Agents auxilliaires |
|---|
| Anti-Xa |
| |
|
|
